OsI_01383 Antibody

What is OsI_01383 Antibody and what is its target protein?

OsI_01383 Antibody (CSB-PA589815XA01OFF) is a polyclonal antibody raised in rabbits against the recombinant Oryza sativa subsp. indica (Rice) OsI_01383 protein. The target protein is identified by UniProt accession number A2WNF5 . This antibody has been specifically developed for research applications in rice biology, with validated applications including ELISA and Western Blot techniques .

Methodologically, researchers should note that this antibody recognizes the native conformation of the OsI_01383 protein in rice samples. The antibody has undergone affinity purification using the target antigen, which enhances its specificity compared to crude serum alternatives .

What are the validated applications for OsI_01383 Antibody?

OsI_01383 Antibody has been validated for the following applications:

• Enzyme-Linked Immunosorbent Assay (ELISA)

• Western Blotting (WB)

When using this antibody for these applications, researchers should implement proper experimental controls as recommended by the International Working Group for Antibody Validation, including:

• Positive controls: Rice samples known to express OsI_01383

• Negative controls: Non-rice samples or samples where the target protein is absent

• Secondary antibody-only controls to assess non-specific binding

• Blocking peptide controls where appropriate

Such validation practices are critical for ensuring experimental reproducibility, particularly when publishing results in peer-reviewed journals.

What are the optimal storage conditions for OsI_01383 Antibody?

For maximum stability and retention of immunoreactivity, OsI_01383 Antibody should be stored at -20°C or -80°C immediately upon receipt . Researchers should note the following methodological considerations:

• Avoid repeated freeze-thaw cycles, as this can lead to antibody degradation and reduced binding efficacy

• If frequent use is anticipated, consider preparing small aliquots to minimize freeze-thaw events

• The antibody is formulated in a storage buffer containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative

• Working dilutions should be prepared fresh on the day of experiment

• For short-term storage (1-2 weeks), 4°C is acceptable for diluted working solutions

These storage recommendations align with general best practices for antibody handling as outlined in antibody characterization literature .

What controls should be implemented when using OsI_01383 Antibody in Western blotting?

When designing Western blot experiments with OsI_01383 Antibody, researchers should implement a comprehensive set of controls based on the "five pillars" of antibody characterization:

• Genetic strategy controls: Where feasible, include samples from OsI_01383 knockout or knockdown rice plants to confirm antibody specificity

• Orthogonal strategy controls: Compare protein expression levels detected by the antibody with mRNA expression data for OsI_01383 obtained through RT-PCR or RNA-seq

• Independent antibody strategy: If available, validate results using a second antibody targeting a different epitope of OsI_01383

• Positive and negative tissue controls: Include samples known to express or lack the target protein

• Loading controls: Implement appropriate housekeeping protein detection to normalize protein loading

Implementing these controls will substantially increase confidence in experimental results and address potential reviewers' concerns regarding antibody specificity .

How should OsI_01383 Antibody be validated for immunohistochemistry experiments in rice tissues?

While OsI_01383 Antibody has not been explicitly validated for immunohistochemistry (IHC) applications according to the product datasheet , researchers intending to use it for this purpose should conduct thorough validation following these methodological steps:

• Tissue preparation optimization: Test multiple fixation protocols (e.g., paraformaldehyde, ethanol, acetone) to determine which best preserves the epitope while maintaining tissue morphology

• Antigen retrieval assessment: Evaluate different antigen retrieval methods (heat-induced vs. enzymatic) to maximize signal while minimizing background

• Titration experiments: Perform antibody dilution series (typically 1:100 to 1:2000) to identify optimal concentration that maximizes signal-to-noise ratio

• Positive and negative controls: Include tissues known to express or lack OsI_01383 protein

• Comparison with mRNA expression: Correlate immunostaining patterns with in situ hybridization data for OsI_01383 transcript

• Peptide competition assay: Pre-incubate antibody with excess immunizing peptide to confirm binding specificity

This validation workflow aligns with recommendations from the antibody characterization literature, which emphasizes that antibodies suitable for Western blotting may require additional validation for IHC applications due to differences in protein conformation and epitope accessibility .

What strategies can address weak or absent signals when using OsI_01383 Antibody in Western blotting?

When confronting weak or absent signals in Western blot experiments with OsI_01383 Antibody, researchers should systematically investigate potential causes using this methodological framework:

• Sample preparation issues:

  • Ensure complete protein extraction using appropriate buffer systems for plant tissues

  • Verify protein integrity by Ponceau S staining of membranes

  • Consider using protease inhibitor cocktails optimized for plant tissues

• Antibody-related factors:

  • Verify antibody activity with a positive control sample

  • Test different antibody concentrations (typically 1:500 to 1:2000)

  • Extend primary antibody incubation time (overnight at 4°C)

  • Consider using signal enhancement systems (e.g., biotin-streptavidin amplification)

• Protocol optimization:

  • Modify blocking conditions (test BSA vs. non-fat dry milk)

  • Increase protein loading amount (50-100 μg total protein per lane)

  • Optimize membrane transfer conditions (time/voltage)

  • Consider using PVDF membrane instead of nitrocellulose for potentially higher protein binding capacity

• Detection system enhancement:

  • Use highly sensitive ECL substrates or consider fluorescent secondary antibodies

  • Extend film exposure time or increase imaging sensitivity

Each troubleshooting step should be systematically documented to identify the critical variables affecting experimental outcome, consistent with rigorous antibody validation practices .

How can cross-reactivity with non-target proteins be assessed and mitigated when using OsI_01383 Antibody?

Cross-reactivity assessment is crucial for ensuring experimental specificity, particularly with polyclonal antibodies like OsI_01383 Antibody. Researchers should implement the following methodological approach:

• Comprehensive cross-reactivity testing:

  • Perform Western blotting with protein extracts from closely related rice subspecies

  • Include protein samples from model plants (Arabidopsis) and unrelated plant species

  • Compare banding patterns across diverse samples to identify potential cross-reactive proteins

• Mitigation strategies:

  • Implement more stringent washing conditions (higher salt concentration, longer wash times)

  • Optimize blocking conditions to reduce non-specific binding

  • Consider pre-adsorption of the antibody with proteins from non-target species

• Validation through orthogonal techniques:

  • Confirm protein identity using mass spectrometry of immunoprecipitated samples

  • Compare antibody-based detection with gene expression data

• Advanced specificity control:

  • If available, use CRISPR/Cas9 knockout lines of OsI_01383 as a definitive negative control

  • Employ RNAi-mediated knockdown samples to verify signal reduction correlates with decreased target expression

These approaches align with the International Working Group for Antibody Validation recommendations, particularly the "genetic strategies" and "orthogonal strategies" pillars of antibody validation .

How can OsI_01383 Antibody be effectively used in co-immunoprecipitation experiments to study protein-protein interactions?

While co-immunoprecipitation (Co-IP) is not listed among the validated applications for OsI_01383 Antibody , researchers interested in using this antibody for investigating protein-protein interactions should follow this methodological workflow:

• Preliminary validation:

  • Confirm antibody specificity via Western blotting

  • Verify the antibody can recognize native (non-denatured) OsI_01383 protein

• Optimization of immunoprecipitation conditions:

  • Test different lysis buffers with varying detergent concentrations to preserve protein-protein interactions

  • Determine optimal antibody amount for efficient capture (typically 2-5 μg per reaction)

  • Compare different coupling strategies (direct antibody addition vs. pre-binding to protein A/G beads)

• Experimental design for interaction studies:

  • Include proper negative controls (non-immune IgG from the same species)

  • Consider crosslinking approaches to stabilize transient interactions

  • Implement stringent washing steps to remove non-specific binding proteins

• Interaction verification:

  • Confirm putative interactions through reciprocal Co-IP when possible

  • Validate interactions using orthogonal methods (e.g., yeast two-hybrid, FRET)

  • Consider mass spectrometry analysis of immunoprecipitated complexes for unbiased interaction discovery

This approach incorporates the "immunocapture MS strategies" pillar of antibody validation, which can simultaneously verify antibody specificity and identify novel interacting partners .

What considerations are important when using OsI_01383 Antibody in chromatin immunoprecipitation (ChIP) experiments?

Chromatin immunoprecipitation represents an advanced application that requires extensive validation beyond the manufacturer's listed applications for OsI_01383 Antibody . Researchers intending to use this antibody for ChIP should consider:

• Preliminary characterization:

  • Determine if OsI_01383 protein has known or predicted DNA-binding domains

  • Verify nuclear localization of the target protein through subcellular fractionation experiments

  • Confirm antibody specificity under ChIP-compatible fixation conditions

• Protocol optimization for plant tissues:

  • Adjust crosslinking conditions (formaldehyde concentration and incubation time) for rice tissues

  • Optimize sonication parameters to generate appropriate DNA fragment sizes (200-500 bp)

  • Develop effective nuclei isolation procedures for rice tissues

• ChIP-specific controls:

  • Include input DNA controls for normalization

  • Implement IgG controls from the same species as the primary antibody

  • Target known gene regions as positive and negative controls

• Data validation:

  • Confirm enrichment at predicted genomic loci using ChIP-qPCR

  • Validate findings with orthogonal methods (e.g., EMSA, reporter gene assays)

  • Consider genome-wide approaches (ChIP-seq) for comprehensive binding site identification

Given that ChIP represents an application beyond the manufacturer's validated uses, researchers should perform extensive preliminary validation before committing to large-scale experiments with this antibody.

How should OsI_01383 Antibody be used in multiplex immunofluorescence experiments with other antibodies?

For researchers interested in co-localization studies using OsI_01383 Antibody alongside other antibodies, the following methodological considerations are important:

• Antibody compatibility assessment:

  • Verify that secondary antibodies do not cross-react with primaries from different species

  • Test antibodies individually before combining to establish baseline staining patterns

  • Ensure spectral separation between chosen fluorophores to minimize bleed-through

• Sequential staining optimization:

  • Determine optimal order of antibody application (typically start with lowest concentration)

  • Implement complete blocking steps between sequential antibody applications

  • Consider using directly conjugated primary antibodies to reduce protocol complexity

• Signal separation strategies:

  • Employ spectral unmixing algorithms during image acquisition if using closely related fluorophores

  • Implement fluorophore quenching steps between sequential antibody staining if using the same species

• Controls for multiplex experiments:

  • Include single-antibody controls alongside multiplex samples

  • Perform antibody omission controls to assess non-specific binding

  • Include biological controls where co-localization is known to be present or absent

This approach allows for rigorous co-localization studies while minimizing the risk of artifactual results due to antibody cross-reactivity or spectral overlap.

What are the considerations for quantifying OsI_01383 protein levels using this antibody in different experimental contexts?

Accurate protein quantification using OsI_01383 Antibody requires careful attention to methodological details across different experimental platforms:

• Western blot quantification:

  • Establish linear dynamic range of detection through standard curve analysis

  • Use appropriate normalization controls (housekeeping proteins)

  • Implement image analysis software with background subtraction capabilities

  • Consider using fluorescent secondary antibodies for wider linear range than chemiluminescence

• ELISA-based quantification:

  • Develop standard curves using recombinant OsI_01383 protein

  • Optimize sample dilution to ensure measurements fall within the linear range of detection

  • Implement technical replicates (minimum triplicate measurements)

• Immunohistochemistry quantification:

  • Use consistent acquisition parameters across all samples

  • Implement automated image analysis algorithms to reduce subjective interpretation

  • Report data as relative values compared to appropriate controls

• Flow cytometry applications (if relevant):

  • Establish proper gating strategies based on negative controls

  • Use median fluorescence intensity rather than mean for more robust quantification

  • Include calibration beads for inter-experiment normalization

These quantification approaches should be validated using samples with known differences in OsI_01383 expression levels to confirm the ability to detect biologically relevant changes .

How should researchers interpret multiple bands detected by OsI_01383 Antibody in Western blot experiments?

The observation of multiple bands in Western blots using OsI_01383 Antibody requires systematic investigation and careful interpretation:

• Potential biological explanations:

  • Post-translational modifications (phosphorylation, glycosylation, etc.)

  • Alternative splice variants of the OsI_01383 gene

  • Protein degradation products

  • Protein complexes resistant to denaturation

• Validation approaches:

  • Compare observed band patterns with predicted molecular weights of known isoforms

  • Use phosphatase or glycosidase treatments to identify modified forms

  • Implement different sample preparation methods to assess degradation contribution

  • Compare patterns across different tissue types and developmental stages

• Experimental verification strategies:

  • Perform mass spectrometry analysis of excised bands to confirm identity

  • Compare with expression patterns in knockout/knockdown samples

  • Correlate with transcript analysis of known splice variants

• Reporting recommendations:

  • Document all observed bands with molecular weight markers

  • Discuss potential explanations for unexpected bands

  • Clearly indicate which band(s) are considered to represent the target protein

This approach aligns with antibody characterization guidelines that emphasize the importance of thoroughly investigating and reporting all observed binding patterns, rather than selectively focusing on expected results .

What strategies can address contradictory results between OsI_01383 Antibody-based detection and other methods of protein or gene expression analysis?

When researchers encounter discrepancies between antibody-based detection of OsI_01383 and other experimental approaches, a systematic reconciliation process should be implemented:

• Analytical framework for contradictions:

  • Document specific nature of discrepancies (presence/absence, quantity, localization)

  • Review literature for known post-transcriptional regulation of similar proteins

  • Consider temporal aspects (protein stability vs. mRNA turnover rates)

• Technical validation:

  • Re-validate antibody specificity under the specific experimental conditions

  • Assess method sensitivity limits for all techniques being compared

  • Evaluate sample preparation differences that might affect detection

• Biological reconciliation approaches:

  • Investigate post-transcriptional regulatory mechanisms (miRNA regulation, translation efficiency)

  • Consider protein stability and turnover rates that may differ from mRNA dynamics

  • Examine potential developmental or stress-induced regulation

• Advanced resolution strategies:

  • Implement pulse-chase experiments to assess protein turnover

  • Use ribosome profiling to examine translation efficiency

  • Apply targeted mass spectrometry for absolute protein quantification

This comprehensive approach acknowledges that discrepancies between different detection methods often reveal important biological insights rather than simply representing technical artifacts, consistent with the orthogonal validation pillar of antibody characterization .

How can OsI_01383 Antibody be utilized in comparative studies across different rice varieties and related species?

OsI_01383 Antibody offers valuable opportunities for comparative protein expression studies, which can be approached methodologically as follows:

• Cross-species reactivity assessment:

  • Test antibody against protein extracts from different rice subspecies (japonica, indica)

  • Evaluate recognition of homologs in wild rice species and related cereals

  • Quantify relative binding affinity across species through titration experiments

• Comparative expression analysis:

  • Implement standardized protein extraction methods across all samples

  • Use consistent loading controls appropriate for cross-species comparison

  • Quantify relative expression levels with reference to standard curves

• Structural and functional correlation:

  • Sequence the OsI_01383 homologs in species showing differential antibody reactivity

  • Map epitope regions to identify conserved and variable domains

  • Correlate protein expression patterns with phenotypic traits of interest

• Evolutionary analysis integration:

  • Combine protein expression data with phylogenetic analysis of gene sequences

  • Investigate selective pressures on protein domains recognized by the antibody

  • Identify potential neofunctionalization or subfunctionalization events

This approach can provide valuable insights into protein evolution within the Oryza genus while also establishing the utility and limitations of this antibody for comparative studies.

What are the considerations for using OsI_01383 Antibody in studying protein expression changes under different environmental stresses?

Plant response to environmental stresses often involves complex changes in protein expression, which can be effectively studied using OsI_01383 Antibody with these methodological considerations:

• Experimental design for stress studies:

  • Implement controlled stress application with precise documentation of conditions

  • Include appropriate time-course sampling to capture dynamic responses

  • Maintain consistent harvesting and protein extraction procedures across treatments

• Technical considerations:

  • Assess whether stress conditions affect reference protein expression

  • Consider using total protein staining (Ponceau S, SYPRO Ruby) for normalization

  • Implement technical and biological replicates to account for stress response variability

• Data interpretation framework:

  • Distinguish between changes in protein abundance vs. post-translational modifications

  • Correlate protein changes with physiological and morphological responses

  • Compare with transcriptomic data to identify potential regulatory mechanisms

• Validation approaches:

  • Confirm stress-induced changes using orthogonal methods

  • Perform functional studies to assess biological significance of observed changes

  • Compare responses across different rice varieties or mutant lines

This methodology enables robust investigation of OsI_01383 protein's potential role in stress responses while adhering to best practices in plant stress biology research.

What emerging technologies might enhance the utility of OsI_01383 Antibody in rice research?

Several cutting-edge technologies can potentially expand the research applications of OsI_01383 Antibody:

• Single-cell protein analysis:

  • Adaptation of antibody for use in mass cytometry (CyTOF) for single-cell protein quantification

  • Integration with single-cell transcriptomics for multi-omics analysis

  • Development of in situ PLA (Proximity Ligation Assay) protocols for tissue-specific interaction studies

• Advanced imaging applications:

  • Super-resolution microscopy techniques for subcellular localization

  • Expansion microscopy protocols adapted for plant tissues

  • Live-cell imaging using cell-permeable nanobody derivatives

• Proteome-wide interaction mapping:

  • Adaptation for proximity-dependent biotin labeling approaches (BioID, APEX)

  • Development of antibody-based protein complex purification for structural studies

  • Integration with cross-linking mass spectrometry for interaction interface mapping

• Functional modulation applications:

  • Development of intrabodies for protein function perturbation in vivo

  • Targeted protein degradation approaches using antibody-based degraders

  • Optogenetic control of protein function through antibody-based tethering

These emerging technologies represent promising directions for expanding the research utility of OsI_01383 Antibody beyond its current validated applications.

How might findings from OsI_01383 protein studies contribute to broader understanding of recurrent pregnancy loss in humans?

• Comparative functional genomics:

  • Identification of potential human homologs of plant proteins through bioinformatic analysis

  • Investigation of functional conservation across evolutionarily distant species

  • Translation of research techniques from plant to human systems

• Immunological research translation:

  • Adaptation of antibody characterization protocols for clinical biomarker development

  • Application of specificity validation approaches to improve diagnostic antibodies

  • Development of standardized reporting for antibody-based diagnostics

• Methodological knowledge transfer:

  • Implementation of rigorous validation frameworks across research domains

  • Adaptation of multiplexing techniques for complex sample analysis

  • Development of quantification standards applicable to both research and clinical settings